Soussi T, Jonveaux P
Unité de Génétique Moléculaire et Cellulaire des Leucémies, Unité INSERM 301, Paris, France.
Nouv Rev Fr Hematol (1978). 1991;33(6):477-80.
Mutations of the tumor suppressor gene p53 are found in a wide variety of human tumors. In hematological malignancies, p53 alterations are involved in the evolution of chronic phase CML to myeloid blast crisis. p53 mutations were also found associated with Burkitt lymphoma (35%) and its leukemic counterpart, L3 type B-cell acute lymphoblastic leukemia (60%). These observations suggest that several common mechanisms are involved in the transformation process of these two hematological disorders.
肿瘤抑制基因p53的突变在多种人类肿瘤中均有发现。在血液系统恶性肿瘤中,p53改变参与慢性期慢性粒细胞白血病向髓系母细胞危象的演变。p53突变还被发现与伯基特淋巴瘤(35%)及其白血病对应类型,即L3型B细胞急性淋巴细胞白血病(60%)相关。这些观察结果表明,这两种血液系统疾病的转化过程涉及几种共同机制。